Childhood Lymphoma — Trials

Childhood Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

98 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02166463	Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma	active not recruiting	Phase 3	600	National Cancer Institute (NCI)NIH	3	Jul 29, 2026	clinicaltrials
NCT04881838	CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL	active not recruiting	Phase 3	172	Children's Cancer Group, ChinaNETWORK	1	Mar 19, 2026